Protara Therapeutics
IPOPublic · New York, United States · $45.0M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Business Model
- B2B
- Website
- protaratx.com
- Total Funding
- $45.0M
- Last Round
- $45.0M Private EquityJan 2022
- Rounds
- 1
- Type
- Public
About
Clinical-stage biopharmaceutical company developing transformative therapies for cancer and rare diseases.
Summary
Protara Therapeutics is a Biotech company based in New York, United States. It has raised $45.0M in total across 1 round, most recently a $45.0M Private Equity round in Jan 2022. Investors include Armistice Capital and Boxer Capital.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2022
Sign up to see all 3 rounds
IPO through Private Equity — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/protara-therapeutics"><img src="https://indexed.vc/api/badge/company/protara-therapeutics" alt="Protara Therapeutics on Indexed.vc" width="260" height="76" /></a>